Topic Paragraphs
FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide

The Global Reliance Disclosure Program fundamentally transforms how the FDA's regulatory drug and biologic approval decisions are leveraged by health authorities around the world and may accelerate patient access to innovative therapies.

Back to Top